Sort
130,381 grants matching “hiv”
Alterations in Lung Microbiome in Acute and Chronic HIV infection
$796,907Andrew P Fontenot · University Of Colorado Denver · U01 · FY2010 · HL
ELSI Core
$796,905Bradley A. Malin · Vanderbilt University Medical Center · U54 · FY2025 · AG
Biospecimen Analysis
$796,905Suman Ranjan Das · Vanderbilt University Medical Center · U54 · FY2025 · AG
AAV Vectored Delivery of Broadly Neutralizing Antibodies with Optimal Innate Functionality Against HIV
$796,895Alejandro Benjamin Balazs · Massachusetts General Hospital · R01 · FY2023 · AI
Molecular Mechanisms of HIV Post-Integration Latency
$796,877J. David Gladstone Institutes · P01 · FY2004 · AI
bNAb induction by antigenically diverse V1V2 lineage specific SHIVs and SOSIPs
$796,855George M Shaw · University Of Pennsylvania · R01 · FY2017 · AI
bNAb induction by antigenically diverse V1V2 lineage specific SHIVs and SOSIPs
$796,855George M Shaw · University Of Pennsylvania · R01 · FY2019 · AI
bNAb induction by antigenically diverse V1V2 lineage specific SHIVs and SOSIPs
$796,855George M Shaw · University Of Pennsylvania · R01 · FY2020 · AI
bNAb induction by antigenically diverse V1V2 lineage specific SHIVs and SOSIPs
$796,855George M Shaw · University Of Pennsylvania · R01 · FY2018 · AI
Human Genetic determinants of HBV recovery
$796,842David L Thomas · Johns Hopkins University · R01 · FY2022 · AI
COOPERATIVE HUMORAL &CELLULAR IMMUNITY AGAINST HIV/SIV
$796,774Scripps Research Institute · R01 · FY2005 · AI
The TENDAI study: Task shifting to treat depression and HIV medication nonadherence in low resource settings
$796,703Melanie Amna Abas · King'S College London · R01 · FY2018 · MH
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
$796,698Charles W. Flexner · Johns Hopkins University · R24 · FY2024 · AI
Posttranscriptional control of gene expression
$796,657Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
A Multilevel, Multiphase Optimization Strategy for PrEP: Patients and Providers in Primary Care
$796,636Elizabeth Lockhart · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2023 · MD
Immunologic changes associated with three progestin-based contraceptives: characterizing immune profiles over one year and identifying factors that may alter HIV risk
$796,600Lisa Blake Haddad · Emory University · R01 · FY2018 · HD
Adolescent Medicine Trials Network for HIV/AIDS Interve*
$796,597Lawrence D'angelo · Children'S Research Institute · U01 · FY2010 · HD
Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA B
$796,583Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Project 1 - Phase I/II Clinical Trial of L. frutescens in HIV-infected adults
$796,567William Robert Folk · University Of Missouri-Columbia · U19 · FY2008 · AT
TICIPS: HIV/AIDS, Secondary Infections and Immune Modul*
$796,567William Robert Folk · University Of Missouri-Columbia · U19 · FY2008 · AT
Translational studies of hookworm infection in Ghana
$796,540Michael Cappello · Yale University · R01 · FY2022 · AI
The Medical Monitoring Project (MMP) is an on-going, locally and nationally representative supplemental surveillance system that collects data on a stratified sample of HIV-diagnosed adults in the US.
$796,535Lynn Walton-Haynes · California Department Of Public Health · U62 · FY2015 · PS
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$796,534Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2011 · AI
Development and application of a quantitive model for HIV-1 transcriptional activation driven by TAR RNA conformational dynamics
$796,527Hashim M Al-Hashimi · Columbia University Health Sciences · R01 · FY2025 · AI
AmbassADDOrs for Health: Supporting young women's health through girl-friendly drug vendors
$796,464Jenny Xin Liu · University Of California, San Francisco · R01 · FY2021 · MH